L O M Medical International Inc

Underwriting Agreements Filter

EX-1
from 10SB12G/A 1 page Anticipated Cash Flow the Following Chart Represents the Company's Anticipated Cash Flow for the Period From March 1, 2000 to February 29, 2001. However, No Assurances Can Be Given That the Future Results Anticipated by the Following Analysis Will Be Achieved. the Following Analysis May Be Significantly Affected by Certain Factors, Including Certain Risks and Uncertainties Which Could Cause Actual Results to Vary Materially From the Future Results Covered in the Following Analysis. Other Factors Could Also Cause Actual Results to Vary Materially From the Future Results Anticipated in the Following Analysis. Undue Reliance Should Not Be Placed on the Following Analysis. Finally, the Following Analysis Is Based on Facts Existing as of the Date of Amendment No. 3 to the Company's Registration Statement on Form 10-Sb Opening Cash Position Estimated Sales of the Lens-O-Matic $ 417,000 Estimated Proceeds From Issuance of Common Shares $3,000,000 $3,240,000 Cash Out Advertising 5,000 Amoritization 15,000 Automotive 20,000 Consulting Fees 260,000 Director's Fees 30,000 Insurance 30,000 Interest and Bank Charges 1,000 Legal and Accounting 195,000 Lensomatic Product Costs 40,000 Lensomatic Product Market Launch 300,000 Licences, Fees and Dues 2,000 Mail and Courier 15,000 Management Fees 5,000 Office and Administration 36,000 Product Analysis and Market Evaluation 75,000 Promotion and Entertainment 6,000 Rent 45,000 Repairs and Maintenance 1,000 Salaries 206,000 Shares Sales Costs 175,000 Syringe Product Development 1,200,000 Telephone and Utilities 20,000 Travel 40,000 Video Production 15,000 Total Cash Out $2,737,500 Estimated Closing Cash $ 919,500 ==========
12/34/56
EX-1
from 10SB12G 1 page Certificate of Incorporation
12/34/56